Skip to main content
Pluri Inc. logo

Pluri Inc. — Investor Relations & Filings

Ticker · PLUR ISIN · US72942G2030 LEI · 529900OZKMF7JGZMYM81 TA Manufacturing
Filings indexed 2,723 across all filing types
Latest filing 2004-01-13 Proxy Solicitation & In…
Country US United States of America
Listing TA PLUR

About Pluri Inc.

https://pluri-biotech.com/

Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.

Recent filings

Filing Released Lang Actions
Proxy Solicitation & Information Statement 2004
Proxy Solicitation & Information Statement
2004-01-13 English
PRIMARY DOCUMENT
Director's Dealing
2004-01-13 English
Regulatory Filings 2004
Regulatory Filings
2004-01-13 English
PRIMARY DOCUMENT
Director's Dealing
2003-12-30 English
Registration Form 2003
Registration Form
2003-12-29 English
Regulatory Filings 2003
Regulatory Filings
2003-11-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.